International Chemical Investors Group (ICIG) today announced the completion of its acquisition of Sandoz Industrial Products GmbH, a Frankfurt-Höchst based manufacturer of enzyme-based fermentation products and intermediates for the pharmaceutical industry, from Novartis Group.

Sandoz Industrial Products GmbH will be re-named Corden BioChem GmbH and will be associated with the CordenPharma Group, the pharma platform of ICIG. Corden BioChem will be complementary to both ICIG’s pharma activities as well as to its fine chemicals activities within the WeylChem Group. The site represents an important additional building block of fermentation-based production technology for ICIG.

ICIG is focused on the continuation and further development of Corden BioChem with the enzymatic 7-ACA business for antibiotics applications at the Höchst site, serving customers worldwide as well as the CordenPharma Latina site in Italy. 

Read the Full Press Release Here.